Eli Lilly | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
AbbVie USD 1.66B 3.15B 2025-03
Abbott USD 2.15B 372M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.13B 275M 2025-06
Baxter International USD -3000000 286M 2025-03
Biogen USD 744M 432.8M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.54B 455M 2025-01
Merck USD 6.77B 864M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Novartis USD 4.66B 269M 2024-12
Novo Nordisk 37.03B 2.65B 2025-03
Perrigo USD 8.3M 143M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
Prestige Brands USD 73.96M 6.19M 2025-03
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
Sanofi USD 2.32B 2.64B 2024-12
United Therapeutics USD 408.4M 15.1M 2025-06
Zoetis USD 773M 144M 2024-12


Eli Lilly Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.